 |
 |
| company |  |
Technology | |
Products and Services | |
Partnership | |
contact |
|
|
|
Company - Advisors Kent D. Henry, Ph.D., Chief Technology Officer and Founder of Pronghorn Technologies, LLC and Partner of PentaSons Technical Consulting and Contracting. Dr. Kent D. Henry has over 20 years of experience in technical contribution and program management related to the design and development of scientific instrumentation. Dr. Henry has performed in these capacities for both large Fortune 500 companies such as Hewlett-Packard/Agilent and small companies. During his tenure with the latter, Dr. Henry received $4.6M in SBIR and commercial funding over a six-year period to develop advancements in novel chemical measurement systems. Dr. Henry has extensive experience in the design, operation, and fabrication of trace detection systems and led the design, fabrication, testing, and production of low power, networked, battery operated microelectronic systems used in complex, submersible water monitoring for the analysis of intact biological materials using atmospheric pressure ionization mass spectrometry. Dr. Henry also served as the Director of Research and Development for where he managed instruments. Dr. Henry received his Ph.D. degree in analytical chemistry at Cornell University under the supervision of Professor Fred W. McLafferty. Business Skills that we can also draw from as needed: Executive management (P&L responsibility, business plan formulations, budgeting). Project management. Web-based project notebooks. Intellectual property. Personnel management. Corporate representation with customers, suppliers, and technology partners. Directing technical personnel (software, electrical, mechanical, manufacturing, and corporate engineers). Directing technical writers. Writing Grants. Corporate communications using Lotus and Microsoft office products. Denong Wang, Ph.D., Senior Program Director, Center for Cancer Research, Biosciences Division, Stanford Research Institute Dr. Wang received his Ph.D. degree in immunology and glycobiology under the supervision of the late Professor Elvin A. Kabat at Columbia University. Dr. Wang finished his postdoctoral training in the laboratories of Professors Leonard A. Herzenberg and Leonore A. Herzenberg (Department of Genetics, Stanford University) and Professor Bernard F. Erlanger (Department of Microbiology, Columbia University). Prior to joining Stanford Research Institute, he was a Principal Investigator & Director of the Stanford Tumor Glycome Laboratory at Stanford University which is one of the seven key laboratories of the NIH Alliance of Glycobiologists for the Detection of Cancer and Cancer Risk. During 1998-2003, Dr. Wang was the head of Functional Genomics Division, Columbia University Genome Center. Dr. Wang has served with NIH study sections in the areas of postgenomics research and technologies in the past few years. Zhengwei Pan, Ph.D., Associate Professor, University of Georgia. Dr. Pan is an Associate Professor of Physics and Engineering at the Department of Physics and Astronomy, University of Georgia. Dr. Pan is also a member of the University of Georgia’s Nanoscale Science and Engineering Center (NanoSEC). Dr. Pan is a renowned expert in nanomaterial synthesis and nanodevices fabrication. The nanomaterials and nanodevices developed by Dr. Pan have a wide range of applications in biological research, medical science, energy, and national security. Dr. Pan has authored more than eighty articles in peer-reviewed journals and books, including articles published in Nature, Science, J. Am. Chem. Soc., Angew. Chem. Int. Ed., and Phys. Rev. Lett. |
|
Company | Advisors | Core Value | Technology | Products and Services | Partnership | Contact